Pathogenesis of enterovirus infection in central nervous system

IF 3.5 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Biosafety and Health Pub Date : 2023-08-01 DOI:10.1016/j.bsheal.2023.06.001
Congcong Wang , Jichen Li , Ying Liu , Qiang Sun , Zhijun Liu
{"title":"Pathogenesis of enterovirus infection in central nervous system","authors":"Congcong Wang ,&nbsp;Jichen Li ,&nbsp;Ying Liu ,&nbsp;Qiang Sun ,&nbsp;Zhijun Liu","doi":"10.1016/j.bsheal.2023.06.001","DOIUrl":null,"url":null,"abstract":"<div><p>Enteroviruses (EVs) are classified into 15 species according to their sequence diversity. They include four human EV (A, B, C, and D) and three rhinoviruses (A, B, and C), and cause diseases in millions of people worldwide. Generally, individuals with enteroviral infections have mild clinical symptoms, including respiratory illness, vomiting, diarrhea, dizziness, and fever. More importantly, some members of the human EV family are neurotropic pathogens that may cause a wide range of clinical diseases, such as aseptic meningitis and encephalitis. Previously, the EV that caused the most severe neurotropic symptoms was poliovirus (PV), a member of the EV C group. Poliovirus has been eliminated in most countries through a global vaccination campaign. Non-PV EVs infect the central nervous system (CNS) and are the major EVs causing neurological diseases. These human non-PV EVs include EV A (e.g., EV-A71, CVA6, and CVA16), B (e.g., CVA9 and CVB3, CVB5, echovirus 11 [E11], E30, and E7), C (e.g., CVA24), and D (e.g., EV-D68). Here, we review the relationship between EV infection and CNS diseases and advance in the use of cellular receptors and host immune responses during viral infection.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":"5 4","pages":"Pages 233-239"},"PeriodicalIF":3.5000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosafety and Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590053623000757","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Enteroviruses (EVs) are classified into 15 species according to their sequence diversity. They include four human EV (A, B, C, and D) and three rhinoviruses (A, B, and C), and cause diseases in millions of people worldwide. Generally, individuals with enteroviral infections have mild clinical symptoms, including respiratory illness, vomiting, diarrhea, dizziness, and fever. More importantly, some members of the human EV family are neurotropic pathogens that may cause a wide range of clinical diseases, such as aseptic meningitis and encephalitis. Previously, the EV that caused the most severe neurotropic symptoms was poliovirus (PV), a member of the EV C group. Poliovirus has been eliminated in most countries through a global vaccination campaign. Non-PV EVs infect the central nervous system (CNS) and are the major EVs causing neurological diseases. These human non-PV EVs include EV A (e.g., EV-A71, CVA6, and CVA16), B (e.g., CVA9 and CVB3, CVB5, echovirus 11 [E11], E30, and E7), C (e.g., CVA24), and D (e.g., EV-D68). Here, we review the relationship between EV infection and CNS diseases and advance in the use of cellular receptors and host immune responses during viral infection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肠病毒感染中枢神经系统的发病机制
肠道病毒根据其序列多样性可分为15种。它们包括四种人类EV(A、B、C和D)和三种鼻病毒(A、B和C),并在全球数百万人中引起疾病。一般来说,肠道病毒感染者有轻微的临床症状,包括呼吸道疾病、呕吐、腹泻、头晕和发烧。更重要的是,人类EV家族的一些成员是嗜神经病原体,可能导致广泛的临床疾病,如无菌性脑膜炎和脑炎。以前,引起最严重的嗜神经症状的EV是脊髓灰质炎病毒(PV),它是EV-C组的一员。通过全球疫苗接种运动,脊髓灰质炎病毒已在大多数国家被消灭。非PV EV感染中枢神经系统(CNS),是导致神经系统疾病的主要EV。这些人类非PV EV包括EV A(例如EV-A71、CVA6和CVA16)、B(例如CVA9和CVB3、CVB5、回声病毒11[E11]、E30和E7)、C(例如CVA24)和D(例如EV-D68)。在此,我们综述了EV感染与中枢神经系统疾病之间的关系,以及在病毒感染期间细胞受体和宿主免疫反应的使用进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biosafety and Health
Biosafety and Health Medicine-Infectious Diseases
CiteScore
7.60
自引率
0.00%
发文量
116
审稿时长
66 days
期刊最新文献
Biosafety and immunology: An interdisciplinary field for health priority Advances and challenges of mpox detection technology Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression An outbreak of rhinovirus infection in a primary school in Shenyang City, China, in 2022
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1